 |
|
|
| |
Telaprevir Combination Treatment in Hard-to-treat African American, Null Responder G1 Chronic Hepatitis C Patients: Early Data From the OUTLOOK Study
|
| |
| |
Reported by jules Levin
CROI March 3-6 Atlanta 2013
Steven L. Flamm,1 Emily C. Martin,2 Andrew J. Muir,3 Nathan J. Shores,4 Lennox J. Jeffers,5 Stephen A. Harrison,6 Rajender Reddy,7 Mark I. Friedman2
1Northwestern Feinberg School of Medicine, Chicago, IL, USA; 2Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA; 3Duke Clinical Research Institute, Durham, NC, USA; 4Tulane University Health Sciences Center, New Orleans, LA, USA; 5Bruce W Carter VA Medical Center, Miami, FL, USA; 6San Antonio Military Medical Center-Brooke Army Medical Center, Fort Sam Houston, TX, USA; 7University of Pennsylvania, Philadelphia, PA, USA
|
| |
|
|
|
|
|
